Caligan Partners as of Dec. 31, 2023
Portfolio Holdings for Caligan Partners
Caligan Partners holds 11 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Liquidia Corp Com New (LQDA) | 42.0 | $125M | 10M | 12.03 | |
| Alimera Sciences Com New | 24.5 | $73M | 17M | 4.32 | |
| Anika Therapeutics (ANIK) | 8.3 | $25M | 1.1M | 22.66 | |
| Exelixis (EXEL) | 7.4 | $22M | 911k | 23.99 | |
| D Fluidigm Corp Del (LAB) | 5.2 | $16M | 7.0M | 2.21 | |
| Evolus (EOLS) | 4.7 | $14M | 1.3M | 10.53 | |
| Agios Pharmaceuticals (AGIO) | 3.3 | $9.8M | 442k | 22.27 | |
| Y Mabs Therapeutics | 2.4 | $7.2M | 1.0M | 6.82 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.2 | $3.6M | 183k | 19.88 | |
| Adma Biologics (ADMA) | 0.7 | $2.1M | 473k | 4.52 | |
| Recro Pharma | 0.2 | $592k | 1.7M | 0.35 |
